Do You Know

03-05-2023 : 769 Pharmacists work as Medical Representative, of which 39 work as Senior Medical Representative * 02-06-2020 : 216 non Pharmacists work as Medical Representative, and 54 work as Senior Medical Representative * 05-06-2023 : In Lebanon, 88 generic medicinal products are more expensive than their Originators * 31-12-2019 : A medicinal product refused in Europe is marketed in Lebanon * 05-06-2023 : At least 332 medicinal products are available on the Lebanese market and are not available in the country of origin * 05-06-2023 : The price of the most expensive medicine available in Lebanon is 30434557 LL * 05-06-2023 : At least 1309 medicinal products are more expensive in Lebanon than in the countries of origin * 01-01-2019 : Daktavira, a generic of Daklinza, is registered in Lebanon but has no public price * 31-12-2019 : 352 medicinal products have been declared as non-marketed or withdrawn * 09-11-2021 : 64.72% of lebanese pharmacists are female * 31-12-2019 : 486 medicines were submitted to the Ministry of Health for a marketing authorization, and 514 medicines were registered to date * 15-06-2018 : The Minister of Public Health, has decided to suspend the commercialization of AB Slim (Ab Care Medical Herbs), which contains sibutramine, sildenafil and phenolphthalein * 01-06-2020 : Some Non-Marketed medicines are still imported * 01-06-2020 : Ixempra, a medicinal product withdrawn in Europe is imported to lebanon * 01-06-2020 : A vaccine made in India, removed from WHO list of prequalified vaccines, is submitted for registration in Lebanon * 01-06-2020 : Lebanon has 14 CROs, and is ranked as one of the largest countries in the world in clinical studies. According to the WHO, 817 clinical studies are currently conducted in Lebanon. * 05-01-2021 : * 01-10-2023 : Adakveo is now withdrawn from use in the European Union due to lack of therapeutic efficacy *


ATC
ATC Description

ATC

ATC Code ATC Description
L04AA60 L04AA60 Remibrutinib
L04AA61 L04AA61 Nerandomilast
L04AA62 L04AA62 Tolebrutinib
L04AB L04AB Tumor necrosis factor alpha (TNF-α) inhibitors
L04AB01 L04AB01 Etanercept
L04AB02 L04AB02 Infliximab
L04AB03 L04AB03 Afelimomab
L04AB04 L04AB04 Adalimumab
L04AB05 L04AB05 Certolizumab pegol
L04AB06 L04AB06 Golimumab
L04AB07 L04AB07 Opinercept
L04AC L04AC Interleukin inhibitors
L04AC01 L04AC01 Daclizumab
L04AC02 L04AC02 Basiliximab
L04AC03 L04AC03 Anakinra
L04AC04 L04AC04 Rilonacept
L04AC05 L04AC05 Ustekinumab
L04AC07 L04AC07 Tocilizumab
L04AC08 L04AC08 Canakinumab
L04AC09 L04AC09 Briakinumab
L04AC10 L04AC10 Secukinumab
L04AC11 L04AC11 Siltuximab
L04AC12 L04AC12 Brodalumab
L04AC13 L04AC13 Ixekizumab
L04AC14 L04AC14 Sarilumab
L04AC15 L04AC15 Sirukumab
L04AC16 L04AC16 Guselkumab
L04AC17 L04AC17 tildrakizumab
L04AC18 L04AC18 Risankizumab
L04AC19 L04AC19 Satralizumab
Showing 30 of 7196 Records